Title : BTK inhibitors synergise with 5-FU to treat drug-resistant TP53-null colon cancers.

Pub. Date : 2020 Feb

PMID : 31518438






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 BTK inhibitors synergize with 5-FU to treat drug-resistant TP53-null colon cancers. Fluorouracil tumor protein p53 Homo sapiens
2 Using drug-resistant TP53-null colon cancer cells as a model we demonstrated that p65BTK silencing or chemical inhibition overcame the 5-fluorouracil resistance of CRC cell lines and patient-derived organoids and significantly reduced the growth of xenografted tumours. Fluorouracil tumor protein p53 Homo sapiens